DCT
1:21-cv-00314
Bayer Pharma AG v. Mylan Pharma Inc
General
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (11/16/22)
Patent Owner
Operating Company (W)
PACER1:21-cv-00314
Nature of Suit835 ANDA
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
-- | 36% |
Plaintiff
Party
Name | Ratings |
|---|---|
L5A | |
L5A | |
L5A |
Attorney
Name | Ratings |
|---|---|
L5A | |
L5A | |
L5A | |
L5A | |
L5B | |
L5A | |
L5B | |
L4B | |
L4B | |
L4E | |
L3C | |
L5A | |
L5A | |
L4B | |
L4C | |
L3C | |
L3C |
Defendant
Party
Name | Ratings |
|---|---|
L5B | |
L5B | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L4E | |
L4E | |
L4E | |
L4E | |
L3E | |
L2E |
Attorney
Name | Ratings |
|---|---|
L5A | |
L5A | |
L5A | |
L5E | |
L5B | |
L5E | |
Shaw Keller LLPLocal | L4D |
L5D | |
L5E | |
L5E | |
Morris James LLPLocal | L4E |
L5E | |
L1C | |
L4E | |
L5E | |
L5E | |
L3B | |
L4B | |
L1C | |
L3C | |
L5C | |
L5D | |
L5D | |
L4B | |
L4D | |
L3D | |
L2D | |
L3D | |
L5A | |
L4A | |
L3A | |
L3E | |
L5E | |
L3E | |
L5E | |
L5E | |
L1D | |
L3E | |
L5E | |
L5E | |
L2E | |
---- -- | |
Abrams & Bayliss LLPLocal | L2D |
L4E | |
L1D | |
L2E | |
L5B | |
L5C | |
L4E |